Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of β-catenin

Hepatology

Volumn 43, Issue 3, 2006, Pages 415-424

  Lian, Zhaorui ^a   Liu, Jie ^a,e   Li, Li ^a,b   Li, Xianxing ^b   Clayton, Marcy ^a   Wu, Meng Chao ^c   Wang, Hong Yang ^c   Arbuthnot, Patrick ^d   Kew, Michael ^d   Fan, Daiming ^e   Feitelson, Mark A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Chengzheng Hospital   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HEPATITIS B ANTIGEN; HEPATITIS B VIRUS X PROTEIN; RNA; SMALL INHIBITORY RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL GROWTH; CELL STRAIN HEP3B; CELL STRAIN HEPG2; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HEPATITIS B; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPORTER GENE; TRANSACTIVATION; UPREGULATION; URG11 GENE; WILD TYPE;

ADOLESCENT; ADULT; AGED; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATOBLASTOMA; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; UP-REGULATION;

EID: 33645223109     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21053     Document Type: Article

References (46)

1. Beasley RP, Hwang LY. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. New York: Grune & Stratton, Inc., 1984:209-224.
2. Szmuness W. Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association. Prog Med Virol 1978;24:40-69.
3. Vyas GN, Blum HE. Hepatitis B virus infection. Western J Med 1984;140:754-762.
4. Seeger C, Baldwin B, Hornbuckle WE, Yeager AE, Tennant BC, Cote P, et al. WHV is a more efficient oncogenic agent than GSHV in a common host. J Virol 1991;65:1673-1679.
5. Feitelson MA, Duan LX. Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997;150:1141-1157.
6. Wang W, London WT, Lega L, Feitelson MA. HBxAg in liver from carrier patients with chronic hepatitis and cirrhosis. HEPATOLOGY 1991;14:29-37.
7. Jin YM, Yun C, Park C, Wang HJ, Cho H. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J Viral Hepat 2001;8:322-330.
8. Seifer M, Hohne M, Schaefer S, Gerlich WH. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J Hepatol 1991;13(Suppl 4):S61-S65.
9. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. HEPATOLOGY 1994;19:810-819.
10. Ueda H, Ullrich SJ, Ngo L, Feitelson MA, Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;9:41-47.
11. Henkler F, Koshy R. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J Viral Hepat 1996;3:109-121.
12. Lian Z, Liu J, Pan J, Tufan NLS, Zhu M, Arbuthnot P, et al. A cellular gene up-regulated by hepatitis B virus encoded X antigen promotes hepatocellular growth and survival. HEPATOLOGY 2001;34:146-157.
13. Tufan NLS, Lian Z, Liu J, Pan J, Arbuthnot P, Kew M, et al. Hepatitis B x antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia 2002;4:355-368.
14. Lian Z, Liu J, Zhang SM, Clayton MM, Arbuthnot P, Kew M, et al. Up-regulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia 2003;5:229-244.
15. Lian Z, Liu J, Li L, Li X, Arbuthnot P, Kew M, et al. Human S15a is an effector which is upregulated by HBV X protein. Mol Carcinog 2004;40:34-46.
16. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997;275:1787-1790.
17. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hirohashi S. β-Catenin mutation in carcinoma of the uterine endometrium. Cancer Res 1998;58:3526-3528.
18. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000;287:1606-1609.
19. Clevers H, van de Wetering M. TCF/LEF factor earn their wings. Trends Genet 1997;13:485-489.
20. Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML. β-Catenin mutations are frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999;59:1442-1444.
21. Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, et al. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinoma. Oncogene 1999;18:6583-6588.
22. Calvisi DF, Factor VM, Loi R, Thorgeirson SS. Activation of β-catenin during hepatocarcinogenesis in transgenic mouse models: Relationship to phenotype and tumor grade. Cancer Res 2001;61:2085-2091.
23. de La Coste A, Romannolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A 1998;95:8847-8851.
24. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, et al. Activation of the beta-catenin gene in primary hepatocellular carcinoma by somatic alterations involving exon 3. Cancer Res 1998;58:2524-2527.
25. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. β-Catenin mutations as associated with a subset of low stage hepatocellular carcinoma negative for hepatitis B virus with favorable prognosis. Am J Pathol 2000;157:763-770.
26. Buendia MA. Genetics of hepatocellular carcinoma. Sem Cancer Biol 2000;10:185-200.
27. Lian Z, Pan J, Liu J, Zhu M, Arbuthnot P, Kew MC, et al. The translation initiation factor, SUI1, may be a target of HBxAg in hepatocarcinogenesis. Oncogene 1999;18:1677-1687.
28. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Over expression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 2001;61:5703-5706.
29. Shibata T, Ochiai A, Kanai Y, Akimoto S, Gotoh M, Yasui N, et al. Dominant negative inhibition of the association between β-catenin and c-erbB-2 by N-terminally deleted β-catenin suppreses the invasion and metastasis of cancer cells. Oncogene 1996;13:883-889.
30. Nollet F, Berx G, Molemans F, van Roy F. Genomic organization of the human β-catenin gene (CTNNB1). Genomics 1996;32:413-424.
31. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteoperosis in mice. Cell 1991;64:693-702.
32. Itsubo M, Ishikawa T, Toda G, Tanaka M. Immunohistochemical study of expression and cellular localization of the multi-drug resistance gene product P-glycoprotein in primary liver carcinoma. Cancer 1994;73:298-303.
33. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and over-expression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994;54:3107-3110.
34. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metaloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 2002;110:1831-1838.
35. Balsano C, Avantaggiati ML, Natoli G, DeMarzio E, Will H, Perricaudet M, et al. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level. Biochem Biophys Res Commun 1991;176:985-992.
36. Wong CM, Fan ST, Ng IOL. β-Catenin mutation and over-expression in hepatocellular carcinoma. Clinicopathologic and prognostic significance. Cancer 2001;92:136-145.
37. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863-4871, 2002.
38. Carruba G, Cervello M, Micell MD, Farruggio R, Notarbartolo M, Virruso L, et al. Truncated form of β-catenin and reduced expression of wild type catenins feature HepG2 human liver cancer cells. Ann N Y Acad Sci 1999;886:212-216.
39. Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt-β-catenin signaling in hepatoma cells. HEPATOLOGY 2004;39:1683-1693.
40. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. Hepatitis B virus protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 1999;73:7231-7240.
41. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763-1773.
42. Cui J, Zhou XD, Liu YK, Tang ZY, Zile MH. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China. World J Gastroenterol 2001;7:542-546.
43. Ito Y, Kawakatsu H, Takeda T, Sakon M, Nagano H, Sakai T, et al. Activation of c-src gene product in hepatocellular carcinoma is highly correlated with indices of early stage phenotype. J Hepatol 2001;35:68-73.
44. Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 1997;17:6427-6436.
45. Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F, Lopez-Cabrera M. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 2001;20:3323-3331.
46. Lara-Pezzi E, Majano PL, Yanwz-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R, et al. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 2001;34:409-415.